Leukemia section

Leukemia News and Features

For pediatric patients with acute lymphoblastic leukemia (ALL), obesity increases risk of persistent disease

For pediatric patients with acute lymphoblastic leukemia (ALL), obesity increases risk of persistent disease

Obese pediatric patients with acute lymphoblastic leukemia (ALL) are more likely to have minimal residual disease.

Good news for young patients with a leukemia subtype with poor prognosis

Good news for young patients with a leukemia subtype with poor prognosis

For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.

Novel drug safe for patients with leukemia

Novel drug safe for patients with leukemia

Results of a phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy in a heavily pretreated cohort of patients.

For Ph-like acute lymphoblastic leukemia (ALL), tyrosine kinase inhibitors (TKIs) may be effective

For Ph-like acute lymphoblastic leukemia (ALL), tyrosine kinase inhibitors (TKIs) may be effective

Tyrosine kinase inhibitors (TKIs) may be effective for the treatment of acute lymphoblastic leukemia (ALL).

High-risk leukemia subtype becomes more common with age

High-risk leukemia subtype becomes more common with age

Many young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and could benefit from drugs used to treat other types of leukemia.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs